ArticleThe oncologist2019

Postintervention Interleukin-6 (IL-6) Level, Rather than the Pretreatment or Dynamic Changes of IL-6, as an Early Practical Marker of Tumor Response in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.

Yanqin Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.